155 related articles for article (PubMed ID: 31607729)
1. The effect of surgical margin on cancer-specific survival in patients treated with nephron-sparing surgery.
Kizilay F; Eskidemir U; Bahceci T; Simsir A; Ozdemir H; Sarsik B; Turna B
Niger J Clin Pract; 2019 Oct; 22(10):1396-1402. PubMed ID: 31607729
[TBL] [Abstract][Full Text] [Related]
2. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
[TBL] [Abstract][Full Text] [Related]
3. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.
Marchiñena PG; Tirapegui S; Gonzalez IT; Jurado A; Gueglio G
Int Braz J Urol; 2018; 44(3):475-482. PubMed ID: 29368873
[TBL] [Abstract][Full Text] [Related]
4. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
5. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
6. Simple enucleation for the treatment of highly complex renal tumors: Perioperative, functional and oncological results.
Serni S; Vittori G; Frizzi J; Mari A; Siena G; Lapini A; Carini M; Minervini A
Eur J Surg Oncol; 2015 Jul; 41(7):934-40. PubMed ID: 25957967
[TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.
Li G; Zhu D; Gao H; Chen H; Li Y; Niu Y
Clin Transl Oncol; 2019 Jun; 21(6):760-765. PubMed ID: 30443869
[TBL] [Abstract][Full Text] [Related]
8. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
Pertia A; Managadze L; Chkhotua A
Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
[TBL] [Abstract][Full Text] [Related]
9. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
Bigot P; Hétet JF; Bernhard JC; Fardoun T; Audenet F; Xylinas E; Ploussard G; Pignot G; Bessede T; Ouzaid I; Robine E; Brureau L; Merigot de Treigny O; Maurin C; Long JA; Rouffilange J; Hoarau N; Lebdai S; Rouprêt M; Bastien L; Neuzillet Y; Mongiat-Artus P; Verhoest G; Zerbib M; Ravery V; Rigaud J; Bellec L; Baumert H; Chautard D; Bensalah K; Escudier B; Paparel P; Grenier N; Rioux-Leclercq N; Azzouzi AR; Soulié M; Patard JJ
Clin Genitourin Cancer; 2014 Feb; 12(1):e19-27. PubMed ID: 24210610
[TBL] [Abstract][Full Text] [Related]
10. Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.
Fernando A; Fowler S; O'Brien T;
BJU Int; 2016 Jun; 117(6):874-82. PubMed ID: 26469291
[TBL] [Abstract][Full Text] [Related]
11. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Bensalah K; Pantuck AJ; Rioux-Leclercq N; Thuret R; Montorsi F; Karakiewicz PI; Mottet N; Zini L; Bertini R; Salomon L; Villers A; Soulie M; Bellec L; Rischmann P; De la Taille A; Avakian R; Crepel M; Ferriere JM; Bernhard JC; Dujardin T; Pouliot F; Rigaud J; Pfister C; Albouy B; Guy L; Joniau S; van Poppel H; Lebret T; Culty T; Saint F; Zisman A; Raz O; Lang H; Spie R; Wille A; Roigas J; Aguilera A; Rambeaud B; Martinez Piñeiro L; Nativ O; Farfara R; Richard F; Roupret M; Doehn C; Bastian PJ; Muller SC; Tostain J; Belldegrun AS; Patard JJ
Eur Urol; 2010 Mar; 57(3):466-71. PubMed ID: 19359089
[TBL] [Abstract][Full Text] [Related]
12. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
14. Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma.
López-Costea MÁ; Bonet X; Pérez-Reggeti J; Etcheverry B; Vigués F
Int Urol Nephrol; 2016 May; 48(5):681-6. PubMed ID: 26861062
[TBL] [Abstract][Full Text] [Related]
15. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
[TBL] [Abstract][Full Text] [Related]
16. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.
Cost NG; Sawicz-Birkowska K; Kajbafzadeh AM; Tourchi A; Parigi GB; Guillén G; DeFoor WR; Apoznanski W
Urology; 2014 Jun; 83(6):1388-93. PubMed ID: 24768019
[TBL] [Abstract][Full Text] [Related]
17. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
18. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up.
Janssen MWW; Linxweiler J; Terwey S; Rugge S; Ohlmann CH; Becker F; Thomas C; Neisius A; Thüroff JW; Siemer S; Stöckle M; Roos FC
PLoS One; 2018; 13(5):e0196427. PubMed ID: 29723225
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma.
Lee J; Kim J; Kim JC; Ham WS; Han WK; Rha KH; Choi YD; Jang WS
Yonsei Med J; 2022 Feb; 63(2):173-178. PubMed ID: 35083903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
